TSXV:RTI.H - Post by User
Comment by
Nastysaskyon Nov 30, 2017 7:08pm
![](https://assets.stockhouse.com/kentico-cms/0340-00/images/Sprite.svg#id_Post_Views_Icon)
157 Views
Post# 27068246
RE:RE:License ANY day now...
RE:RE:License ANY day now...cheezieboy wrote: Isn't the license to be approved next week only an R&D license for their research lab? It's not the production license- isn't that coming mid calendar 2018?
yep. But the R&D license allows them to start isolating the terpines, and cabinoids for research purposes. Hence Aroroa's bid for Cannimed. Mary Jane as a compound is just beginning to be explored scientifically. If RTI's extraction and isolation technology is what they say it is, they'll be ground floor at the beginning of a completely new scientific and recreational industry with vast economic potential. As long as their tech is what they say it is, and management aren't complete morons RTI should be huge.
I think you have to value RTI as a tech/biotech start up rather than an industrial producer of goods.